neoadjuvant chemotherapy
Showing 1 - 25 of >10,000
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of
Not yet recruiting
- Organoids
- +2 more
- Biopsy
- (no location specified)
Nov 24, 2023
Colon Cancer Trial (Neoadjuvant chemo)
Not yet recruiting
- Colon Cancer
- Neoadjuvant chemotherapy
- (no location specified)
Oct 25, 2023
Micrometastases in Axillary Lymph Nodes in Breast Cancer,
Completed
- Micrometastases
- Neoadjuvant Chemotherapy
- Sentinel lymph node biopsy, axillary lymph node dissection
- (no location specified)
Nov 20, 2023
New Prognostic Index for Neoadjuvant Chemotherapy Outcome in
Enrolling by invitation
- Ovarian Cancer
- +2 more
- CRS scoring
- Routine blood laboratory testing before treatment
-
Guangzhou, Guangdong, ChinaThe Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023
Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 15, 2023
Surgery After Neoadjuvant Chemotherapy in Locally Advanced
Completed
- Postoperative Complications
- surgery after neoadjuvant chemotherapy
-
Seoul, Korea, Republic ofAsan medical center
Jun 1, 2023
Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
- Epirubicin, Cyclophosphamide, Docetaxel
- (no location specified)
Jun 21, 2023
Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)
Not yet recruiting
- Inflammatory Breast Cancer
- Breast conserving surgery
- Radical modified mastectomy
- (no location specified)
Nov 14, 2023
Sentinel Lymph Node Trial (sentinle lymphnode biopsy)
Not yet recruiting
- Sentinel Lymph Node
- sentinle lymphnode biopsy
- (no location specified)
Nov 11, 2023
Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)
Recruiting
- Nasopharyngeal Carcinoma
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Apr 2, 2023
Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))
Not yet recruiting
- Breast Cancer
- Arm I (No PMRT)
- Arm II (PMRT)
- (no location specified)
Aug 8, 2023
Neoadjuvant Chemo, PD-1 Antibody, Radiotherapy Trial (neoadjuvant chemo combined with PD-1 antibody + radical radiotherapy)
Not yet recruiting
- Neoadjuvant Chemotherapy
- +3 more
- neoadjuvant chemotherapy combined with PD-1 antibody + radical radiotherapy
- (no location specified)
Sep 21, 2022
Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Istanbul (Axillary sentinal lymph node biopsy)
Not yet recruiting
- Breast Cancer
- +2 more
- Axillary sentinal lymph node biopsy
-
İstanbul, Bagcilar, Turkey
- +1 more
Oct 22, 2023
Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Mar 6, 2023
Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)
Not yet recruiting
- Appendiceal Adenocarcinoma
- Colorectal
- Circulating tumoral DNA directed neoadjuvant therapy arm
-
Houston, TexasM D Anderson Cancer Center
Jul 7, 2023
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
Recruiting
- Non-Small Cell Lung Cancer
- Neoadjuvant immunochemotherapy
- Neoadjuvant chemotherapy
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Aug 1, 2023
Extracellular Vesicles in Breast Cancer Patientsin Undergone
Recruiting
- Breast Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri SpA
Apr 14, 2023
Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)
Recruiting
- Breast Cancer
- Dalpiciclib
- +4 more
-
Shijiazhuang, Hebei, ChinaThe Fourth Hospital of Hebei Medical University
Oct 25, 2023
Breast Cancer Trial in Toronto (ICG guided sentinel lymph node biopsy)
Recruiting
- Breast Cancer
- ICG guided sentinel lymph node biopsy
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 13, 2023
Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)
Recruiting
- Urinary Bladder Cancer
- Carboplatin-Gemcitabine Cisplatin-Gemcitabine
-
Assiut, EgyptAssiutU
Apr 22, 2023
Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)
Not yet recruiting
- Locally Advanced Vulvar Carcinoma
- Squamous Cell Carcinoma of the Vulva
- Paclitaxel and Carboplatin
- Chemoradiation
- (no location specified)
Jun 6, 2023
Pancreatic Cancer Trial in United States (Gemcitabine and Capecitabine)
Recruiting
- Pancreatic Cancer
- Gemcitabine and Capecitabine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Dec 31, 2022
Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast
Recruiting
- Breast Cancer
- Response monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Neoadjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
Not yet recruiting
- Upper Excretory Tract Tumors
- Patients with Upper excretory tract tumors
- (no location specified)
Jan 3, 2023